Historical moh News Stories
Molina Healthcare (MOH): Q1 Shock, Cash Flow Rise!
Molina Healthcare reported a steep GAAP EPS decline driven by a $93M impairment, but delivered a surge in operating cash flow and reaffirmed 2026 guidance. The stock remains influenced by S&P index reclassification and persistent Medicaid enrollment pressures.
Molina Healthcare Upgrades vs. 2026 Profit Cut Now
Molina Healthcare (MOH) saw heavy analyst activity this week: Bank of America upgraded the stock to Buy with a $250 target while Morgan Stanley lifted its target to $146. Those bullish signals clashed with Molina’s guidance indicating 2026 profit below analyst expectations as rising medical costs weigh on margins. Sector strength from peers such as UnitedHealth provided additional upside, creating mixed but high‑impact catalysts for the stock.
Molina Healthcare S&P Exit Triggers Volatility Now
Molina Healthcare (MOH) will be removed from the S&P 500 and added to the S&P SmallCap 600 ahead of March 23, 2026. That mechanically-driven rebalancing, plus an upcoming Q1 earnings release on April 22 and conference call on April 23, creates a window of elevated volume and short-term price volatility driven by index flows rather than fundamentals.
Molina Healthcare Drops from S&P 500 Forced Selling
Molina Healthcare (MOH) fell out of the S&P 500 after a Q4 2025 earnings shock and steep guidance cut. The index reclassification, effective March 23, 2026, creates forced selling and short-term volatility while the company works to control medical-cost trends and rebuild margins.
Molina's S&P Exit Spurs Forced Selling Pressure Q1
Molina Healthcare’s removal from the S&P 500 and persistent cost pressures—driven by high medical loss ratios and muted Medicare Advantage rate updates—are creating short-term downside risk through forced index selling and margin compression.
Molina Faces Medicaid Oversight, Medicare Cuts Now
Recent federal and state actions — a tightened CMS oversight bulletin, Minnesota’s proposal to eliminate MCOs, and a near‑flat 2027 Medicare Advantage rate notice — have elevated near‑term operational and margin risks for Molina Healthcare (MOH). This article explains the concrete regulatory moves from the past week, quantifies how they intersect with Molina’s Medicaid and MA exposure, and highlights near‑term catalysts investors should monitor.
Molina Facing Probe; Capital World Cuts MOH Stakes
Molina Healthcare (MOH) has seen fresh headwinds this week after Capital World Investors trimmed its stake and a shareholder-law firm launched an inquiry into company leadership. Analyst downgrades and persistent managed-care margin pressure have amplified volatility for the S&P 500 insurer. This article summarizes the events, market reactions, and near-term implications for investors.
Molina Healthcare Q4 Loss Sparks Sharp Stock Drop.
Molina Healthcare reported a surprise Q4 loss and drastically lowered guidance, triggering a steep share decline and strategic withdrawal from Medicare Advantage Part D. This article summarizes the confirmed financial hits, market reaction, operational pivots, and investor watchpoints.
Molina Healthcare (MOH): 28% Plunge, Rally
Molina Healthcare’s stock swung dramatically after a steep February earnings-guidance shock and Medicaid adjustments knocked 2026 EPS expectations lower. Short-term rebounds followed amid elevated volume and a shareholder probe, but structural cost pressures and governance questions keep downside risk prominent.
Molina Healthcare Plunges After 2026 Profit Shock.
Molina Healthcare (MOH) plunged after a surprise Q4 loss and a dramatic cut to 2026 profit guidance. Operational hits—retroactive Medicaid adjustments, Florida contract implementation costs, a Medicare Advantage exit and a $93M impairment—drove the sell-off and prompted concern about liquidity and margin pressure despite contrarian investor interest.